Author

Xu Huang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

P1.057. Early Recurrence After Neoadjuvant Therapy and Esophagectomy for Locally Advanced ESCC

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Despite improved interventions with radical esophagectomy accompanied by perioperative systematic therapy, recurrence remains frequent in locally advanced esophageal squamous cell carcinoma (ESCC). A clinically important subset experiences early recurr...

F. Su, Subinuer Maimaiti, Xu Huang et al. · Diseases of the esophagus · 0 citations

Open access Aug 2026

PD01.03. Impact of Surgical Timing on Survival by Pathological Response Status in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant chemoradiotherapy (nCRT) followed by esophagectomy is standard treatment for esophageal squamous cell carcinoma (ESCC). Optimal surgical timing after nCRT remains unclear. Patients achieving pathological complete response (pCR) may demonstr...

Xu Huang, Fangyi Liu, Zitao Jian et al. · Diseases of the esophagus · 0 citations

Aug 2026

P1.082. Neoadjuvant Chemoradiotherapy-to-Surgery Interval and Survival Stratified by Pathological Response in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study

Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is the standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, the optimal interval between nCRT completion and surgery remains undetermined, particularly rega...

Xu Huang, Fangyi Liu, Han Tang et al. · Diseases of the esophagus · 0 citations